Implications of IOM PEPFAR evaluation for Global Fund

"The U.S. Institute of Medicine of the National Academy of Sciences recently completed a congressionally mandated impact evaluation of the PEPFAR HIV/AIDS program, which is the single largest ever health initiative of the U.S. government," Todd Summers, senior adviser at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog. Summers highlights four key points from the report that he says "should resonate with Global Fund [to Fight AIDS, Tuberculosis, and Malaria] leadership." Those points include: "Prevention of new HIV infections must be a higher priority"; "[w]e have to get better at measuring success"; "[e]ven when we can measure impact, attribution of benefits to specific funders is rarely possible"; and "[h]igher investment is needed to equip countries to collect and analyze data to measure progress and inform decision-making" (3/11).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New strategy targets rare B cells for effective HIV vaccine development